%PDF-1.4
%
74 0 obj
<>
endobj
71 0 obj
<>
endobj
127 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-11-29T16:32:44Z
2024-03-28T05:50:30-07:00
QuarkXPressª: AdobePS 8.6 (219)
2024-03-28T05:50:30-07:00
application/pdf
Heather
200358.oct
uuid:12b14d44-1dd2-11b2-0a00-5d0827bd3700
uuid:12b14d46-1dd2-11b2-0a00-5b0000000000
endstream
endobj
60 0 obj
<>
endobj
61 0 obj
<>
endobj
75 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
9 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
22 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
40 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
145 0 obj
[149 0 R]
endobj
146 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.06 612 -792 re
W n
BT
/CS0 cs 0 0 0 1 scn
/GS1 gs
/TT0 1 Tf
0.0768 Tw 10 0 0 10 54 713.1616 Tm
(binding was present in quiescent endothelial cells, Ferrara,)Tj
/TT1 1 Tf
0.1635 Tw 0 -1.2 TD
(et al)Tj
/TT0 1 Tf
-0.00011 Tc 0.1636 Tw 2.3266 0 Td
[(hypothesized that )17.8 (VEGF in the vascular wall is not)]TJ
0 Tc 0.03059 Tw -2.3266 -1.2 Td
(limited to the induction of growth )Tj
/TT1 1 Tf
-0.00011 Tc 13.9592 0 Td
(per se)Tj
/TT0 1 Tf
0 Tc [-0.3 (, but is involved in)]TJ
0.15981 Tw -13.9592 -1.2 Td
(preventing apoptosis of endothelial cells, in regression of)Tj
0.01131 Tw T*
(blood vessels, and in regulating vessel function under phys-)Tj
0.02499 Tw T*
(iologic conditions)Tj
0 Tw 6.5 0 0 6.5 126.186 656.4615 Tm
(7)Tj
10 0 0 10 129.436 653.1616 Tm
(.)Tj
-0.00011 Tc -0.03461 Tw -6.3436 -1.2 Td
[(Our results showed that plasma )17.8 (VEGF levels are raised in)]TJ
0 Tc 0.14391 Tw -1.2 -1.2 Td
[(the acute phase of HSP)-357.1 (compared to the resolution phase)]TJ
0.13921 Tw T*
[(and may be used as a marker of disease activity)64.9 (. Further)39.8 (,)]TJ
0.0867 Tw T*
[(altered intensity of vascular )17.7 (VEGF expression in the acute)]TJ
0.26691 Tw T*
(phase compared with the resolution phase suggests that)Tj
0.0905 Tw T*
(VEGF may play a crucial role in morphological and func-)Tj
0.1087 Tw T*
(tional changes of endothelial cells and inflammatory reac-)Tj
-0.00011 Tc 0.02499 Tw T*
[(tions in HSP)110.7 (.)]TJ
/TT2 1 Tf
0 Tw 0 -2.4 TD
(REFERENCES)Tj
/TT0 1 Tf
0 Tc 0.0249 Tw 8 0 0 8 61 523.1616 Tm
[(1.)-875 (Leugen DW)91.8 (, Cachianes G, Kuang )17.7 (W)54.9 (-J, Goeddel DV)128.9 (, Ferrara N.)]TJ
1.675 -1.25 Td
[(V)111.1 (ascular endothelial growth factor is a secreted angiogenic)]TJ
0 -1.25 TD
(mitogen. Science 1989;246:1306-9. )Tj
-0.00011 Tc -1.675 -1.25 Td
[(2.)-875.1 (Keck PJ, Hauser SD, Krivi G, et al. )17.7 (V)111 (ascular permeability factor)39.7 (, an)]TJ
0 Tc 1.675 -1.25 Td
[(endothelial cell mitogen related to PDGF)79.8 (. Science 1989;)]TJ
0 Tw T*
(246:1309-12.)Tj
0.0249 Tw -1.675 -1.25 Td
[(3.)-875 (Thomas KA. )17.7 (V)111.1 (ascular endothelial growth factor)39.8 (, a potent and)]TJ
1.675 -1.25 Td
(selective angiogenic agent. J Biol Chem 1996;271:603-7.)Tj
-0.00011 Tc -1.675 -1.25 Td
[(4.)-875.1 (Iijima K, )36.8 (Y)100 (oshikawa N, Connolly DT)73.9 (, Nakamura H. Human)]TJ
0 Tc 1.675 -1.25 Td
(mesangial cells and peripheral blood mononuclear cells produce)Tj
T*
[(vascular permeability factor)54.9 (. Kidney Int 1993;44:959-66.)]TJ
-1.675 -1.25 Td
[(5.)-875 (T)69.8 (opaloglu R, )17.7 (T)34.9 (urner C, Clark G. )17.7 (V)111.1 (ascular endothelial growth factor)]TJ
1.675 -1.25 Td
(in idiopathic nephrotic syndrome, transplant rejection and reflux)Tj
T*
[(nephropathy [abstract]. Pediatr Nephrol 1996;10:C1)36.9 (14. )]TJ
-1.675 -1.25 Td
[(6.)-875 (Carmeliet P)110.8 (, Collen D. )17.8 (V)111.1 (ascular development and disorders:)]TJ
1.675 -1.25 Td
(Molecular analysis and pathogenic insights. Kidney Int)Tj
0 Tw T*
(1998;53:1519-49.)Tj
0.02499 Tw -1.675 -1.25 Td
[(7.)-875 (Ferrara N. Role of vascular endothelial growth factor in the)]TJ
1.675 -1.25 Td
(regulation of angiogenesis. Kidney Int 1999;56:794-814.)Tj
-0.00011 Tc -1.675 -1.25 Td
[(8.)-875.1 (W)79.7 (ebb NJA, Bottomley MJ, )17.7 (W)79.7 (atson CJ, Brenchley PEC. )17.7 (V)111 (ascular)]TJ
1.675 -1.25 Td
(endothelial growth factor \(VEGF\) is released from platelets during)Tj
0 Tc T*
[(blood clotting: implications for measurement of circulating )17.8 (VEGF)]TJ
T*
[(levels in clinical disease. Clin Sci 1)36.9 (198;94:395-404.)]TJ
-0.00011 Tc 31.325 51.421 Td
[(9.)-875.1 (Hsu SM, Raine L, Fanger H. Use of avidin-biotin peroxidase)]TJ
0 Tc 1.675 -1.25 Td
[(complex \(ABC\) in immunoperoxidase techniques. )54.9 (A)-219.8 (comparison)]TJ
T*
[(between )54.8 (ABC and unlabeled antibody \(P)91.8 (AP\) procedures. )]TJ
T*
(J Histochem Cytochem 1981;29:557-80.)Tj
-2.175 -1.25 Td
[(10.)-875 (Besbas N, Saatci U, Ruacan S, et al. )17.8 (The role of cytokines in)]TJ
2.175 -1.25 Td
(Henoch-Schonlein purpura. Scand J Rheumatol 1997;26:456-60. )Tj
-0.00011 Tc -2.1381 -1.25 Td
[(1)36.8 (1)-0.1 (.)-875.1 (Furukawa S, Matsubara )17.7 (T)73.9 (,)-0.1 ( )36.8 (Y)100 (one K, Hirano )36.8 (Y)129 (, Okurana K, )36.8 (Y)100 (abuta)]TJ
2.1381 -1.25 Td
[(K. Kawasaki disease dif)17.7 (fers from anaphylactoid purpura and)]TJ
0 Tc T*
(measles with regard to tumor necrosis factor and interleukin 6 in)Tj
T*
(serum. Eur J Pediatr 1992;151:44-7.)Tj
-2.175 -1.25 Td
[(12.)-875 (Besbas N, Erbay )54.8 (A, Saatci U, et al. )17.7 (Thrombomodulin, tissue)]TJ
2.175 -1.25 Td
[(plasminogen activator and plasminogen activator inhibitor)19.8 (-1 in)]TJ
T*
(Henoch-Schonlein purpura. Clin Exp Rheumatol 1998;16:95-8.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(13.)-875.1 (Soylemezoglu O, Sultan N, Gursel )17.7 (T)73.9 (,)-0.1 ( Buyan N, Hasanoglu E.)]TJ
0 Tc 2.175 -1.25 Td
[(Circulating adhesion molecules ICAM-1, E-selectin and )17.8 (V)129.1 (on)]TJ
T*
[(W)39.8 (illebrand factor in Henoch-Sch\366nlein purpura. )54.8 (Arch Dis Child)]TJ
0 Tw T*
(1996;319:1670-1.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(14.)-875.1 (Bernatchez PN, Soker S, Sirois MG. )17.7 (V)111 (ascular endothelial growth)]TJ
0 Tc 2.175 -1.25 Td
[(factor ef)17.8 (fect on endothelial cell proliferation, migration, and platelet)]TJ
T*
(activating factor synthesis is flk-1 dependent. J Biol Chem)Tj
0 Tw T*
(1999;274:31047-54. )Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(15.)-875.1 (Olofsson B, Korpelainen E, Pepper MS, et al. )17.7 (V)111 (ascular endothelial)]TJ
2.175 -1.25 Td
[(growth factor B \(VEGF-B\) binds to )17.7 (VEGF receptor)19.7 (-1 and regulates)]TJ
0 Tc T*
(plasminogen activity in endothelial cells. Cell Biol 1998;95:)Tj
0 Tw T*
[(1)36.9 (1709-14. )]TJ
0.0249 Tw -2.175 -1.25 Td
[(16.)-875 (Maeno N, )17.7 (T)69.8 (akei S, Imanaka H, et al. Increased circulating vascular)]TJ
2.175 -1.25 Td
(endothelial growth factor is correlated with disease activity in)Tj
T*
(polyarticular juvenile rheumatoid arthritis. J Rheumatol)Tj
0 Tw T*
(1999;26:2244-8.)Tj
0.0249 Tw -2.175 -1.25 Td
[(17.)-875 (Li CG, Reynolds G, Ponting JM, et al. Serum levels of )17.7 (VEGF are)]TJ
2.175 -1.25 Td
[(markedly elevated in patients with )17.7 (W)79.8 (egener)-36.9 (\222)55.2 (s granulomatosis. Br J)]TJ
T*
(Rheumatol 1998;37:1303-6.)Tj
-2.175 -1.25 Td
[(18.)-875 (T)69.8 (erai M, )36.8 (Y)100.1 (asukawa K, Narumoto S, et al. )17.7 (V)111.1 (ascular endothelial)]TJ
-0.00011 Tc 2.175 -1.25 Td
[(growth factor in acute Kawasaki disease. )54.8 (Am J Cardiol)]TJ
0 Tc 0 Tw T*
(1999;83:337-9.)Tj
0.0249 Tw -2.175 -1.25 Td
[(19.)-875 (V)60.1 (iac J, Palacio S, Schmitt D, Claudy )54.8 (A. Expression of vascular)]TJ
2.175 -1.25 Td
(endothelial growth factor in normal epidermis, epithelial tumors)Tj
T*
[(and cultured keratinocytes. )54.9 (Arch Dermatol Res 1997;289:158-63.)]TJ
ET
/CS0 CS 0 0 0 1 SCN
54 54 m
558 54 l
S
BT
/TT1 1 Tf
8 0 0 8 54.5 35.9844 Tm
[(T)92 (opaloglu, et al: VEGF in HSP)]TJ
0 Tw 60.9375 -0.0313 Td
(2273)Tj
ET
0 0 0 0 scn
/GS0 gs
101.26 58.45 407.5 -10.84 re
f*
0.5 w
101.26 58.45 407.5 -10.84 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_0 8 Tf
120.092 51 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2001. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_1 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
116 0 obj
<>
endobj
132 0 obj
<>
endobj
82 0 obj
<>
endobj
78 0 obj
<>
endobj
89 0 obj
<>
endobj
88 0 obj
<>
endobj
111 0 obj
<>stream
HdVpTs͋(lb^XG .